Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Researchers discover potential treatment for blinding disease

The discovery of an inflammatory mediator key to the blinding effects of diabetic retinopathy is pointing toward a potential new treatment, Medical College of Georgia researchers said.

18 Jan 2010

Bariatric surgery offers a new hope for obese patients

Obesity is a condition that often follows family lines, but bariatric surgery offers hope for breaking this generational pattern.

18 Jan 2010

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

The Juvenile Diabetes Research Foundation today announced an innovative partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease -- the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial pancreas, a fully automated system to dispense insulin to patients based on real-time changes in blood sugar levels.

18 Jan 2010

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

Thanks in part to more than a decade of preclinical work by Dartmouth researchers, a Japanese biopharmaceutical firm is preparing to develop and market throughout Asia a drug for the treatment of chronic kidney disease (CKD).

18 Jan 2010

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

13 Jan 2010

Majority of doctors appear to ignore FDA warning to screen high-risk medications

A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general.

13 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

Albertsons launches new online community to provide value-driven choices for healthier living

Albertsons, a SUPERVALU company, today launched a new online community, AlbertsonsWellbeing.com, that will provide users with tools to help them make easy, value-driven choices for healthier living.

11 Jan 2010

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

SSHE starts off "Seattle Sutton's 2010 Slim Down" weight loss contest

Seattle Sutton's Healthy Eating (SSHE), the premier meal replacement company in the country, kicks off today its weight loss contest called Seattle Sutton's 2010 Slim Down.

5 Jan 2010

Elevated diabetes risk associated with smoking cessation, but lifestyle changes can help combat risk

Cigarette smoking is a well-known risk factor for type 2 diabetes, but new research from Johns Hopkins suggests that quitting the habit may actually raise diabetes risk in the short term.

5 Jan 2010

Highlights of January 2010 'Ophthalmology'

This month's Ophthalmology, the journal of the American Academy of Ophthalmology, includes a research review of the effects of Vitamins C and E and magnesium on diabetic retinopathy and findings from the first large study of vision problems in Hispanic and African-American infants and young children.

5 Jan 2010

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

OmSanA: A natural dietary supplement for maintaining blood sugar and cholesterol levels

As the nation prepares to watch the ball drop in Times Square, Americans will reminisce about the past year and make resolutions for 2010—many will be focused on getting and remaining healthy—and just being normal. Yes, that’s right…normal.

31 Dec 2009

Service dogs for people with disabilities

When disability or illness makes it difficult to open a door, pick up keys or call for help, a service dog might ease these frustrations of daily living.

30 Dec 2009

Pharmacists can reduce treatment costs and improve outcomes if given the chance

The role of pharmacists hasn't received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.

30 Dec 2009

ADA recommends the A1C test for diabetes screening and diagnosis

New official guidelines for diabetes screening and diagnosis now include a blood test that gives a person's average blood glucose level over the previous 2-3 months.

30 Dec 2009

CoachRx: An interactive website for CIGNA’s customers

As former Surgeon General C. Everett Koop, M.D. once said, “Drugs don’t work in patients who don’t take them.” That’s why CIGNA is introducing CoachRx, an interactive Web site to help CIGNA Home Delivery Pharmacy customers identify their personal barriers to taking their medications, and then providing ways to help people stay on track with the medications they need.

28 Dec 2009

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.

22 Dec 2009

Blood Sugar News and Research

Further Reading

Researchers discover potential treatment for blinding disease

Bariatric surgery offers a new hope for obese patients

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Majority of doctors appear to ignore FDA warning to screen high-risk medications

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Albertsons launches new online community to provide value-driven choices for healthier living

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

SSHE starts off "Seattle Sutton's 2010 Slim Down" weight loss contest

Elevated diabetes risk associated with smoking cessation, but lifestyle changes can help combat risk

Highlights of January 2010 'Ophthalmology'

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

OmSanA: A natural dietary supplement for maintaining blood sugar and cholesterol levels

Service dogs for people with disabilities

Pharmacists can reduce treatment costs and improve outcomes if given the chance

ADA recommends the A1C test for diabetes screening and diagnosis

CoachRx: An interactive website for CIGNA’s customers

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News